Meet the grand expertise at International Conference on Hematology & Blood Disorders takes place on September 22-23, 2025 in Brussels, Belgium. The Conference is a premier event dedicated to advancing the field of hematology by bringing together leading researchers, clinicians, and health care professionals. This conference serves as a vital platform for discussing the latest advancements, research findings, and clinical practices related to blood disorders and hematologic malignancies.
Abstract Submission Deadline
Early Bird Registration
Standard Registration
On-spot Registration
Bnai Zion Medical Center & Technion, Israel
Xuzhou Medical University, china
National Lebanese and Beirut Arab Universities, Lebanon
Aristotle University of Thessaloniki, Greece
Hematology is a rapidly advancing field of science, over the past decade, many innovations and breakthroughs have occurred within this hematology and blood disorder diseases. Treatment protocols for hematological malignancies have grown progressively intricate; for instance, quadruplet treatments became known as the standard of care for multiple myeloma. Global access to hematopoietic stem-cell transplantation has enhanced, with an increase in centers established in low-income and middle-income countries (LMICs), and the development of optimized regimens to avoid and manage post-transplantation complications, including graft-versus-host disease. Innovative therapies have fundamentally transformed the way cancer is treated for hematological malignancies, including bispecific antibodies and CAR T cells. Current research is concentrated on extending this technology to solid tumors and rheumatological disorders, as well as creating more efficient and cost-effective production methods to enhance accessibility to these therapies. The initial gene therapies for sickle cell disease, thalassemia, and hemophilia have received approval, and novel, long-acting factor-replacement medications are transforming the lives of those with hemophilia. There have been little yet significant alterations in our language, such as the transition to patient-first terminology, which more accurately represents the community's requirements. With all these advances, the theme for 2025 hematology conference is emerging trends and technologies in hematology and blood disorders.
We are proud to have the honor of reporting and supporting these remarkable advancements by organizing academic events and bring professionals, doctors, clinicians, researchers and industries together in this field. Despite significant progress over the last decade, considerable obstacles remain. Reflecting on the past decade from a health viewpoint necessitates the inclusion of COVID-19. This global pandemic transformed the world, with repercussions still evident today. Numerous clinical trials encountered challenges in patient enrollment, which subsequently affected analysis. Worker burnout continues, and workforce shortages arise from insufficient specialization in classical hematology. Access to fundamental medicines, including hydroxyurea and factor VIII, in low- and middle-income countries is inadequate. The incorporation of COVID-19 is necessary when reflecting on the past decade from a health perspective. This global pandemic has had a lasting impact on the globe, with its repercussions still being felt. The analysis was subsequently impacted by the challenges that numerous clinical trials encountered in patient enrollment. Insufficient specialization in classical hematology has resulted in workforce shortages, and worker fatigue persists. In low- and middle-income countries, access to essential medications, such as factor VIII and hydroxyurea, is inadequate.
We, the organizing committee of the International Conference on Hematology and Blood Disorders, have been privileged to connect with and support the community and conference. We express our gratitude to professionals, doctors, clinicians, researchers and industries for their ongoing enthusiasm and support of this conference.
Rui Wang
Suqian Affiliated Hospital of Xuzhou Medical University, China
